Triple-negative breast cancer: bridging the gap from cancer genomics to predictive biomarkers

Triple-negative breast cancer (TNBC) represents a challenge clinically due to a lack of response to hormonal and HER2-targeted agents coupled with an aggressive disease course. As the biology of this breast cancer subtype is better understood, it is clear that TNBC is a heterogeneous disease and one...

Full description

Bibliographic Details
Main Authors: S. Lindsey Davis, S. Gail Eckhardt, John J. Tentler, Jennifer R. Diamond
Format: Article
Language:English
Published: SAGE Publishing 2014-05-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/1758834013519843

Similar Items